| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |